Madhusudan Kela's Game-Changing Portfolio Moves: Find Out If You're Investing in These Top Picks!

In the world of investing, the strategies of renowned investors often attract significant attention, particularly in India, where names like Madhusudan Kela stand out. Regarded as one of the nation’s top investors, Kela’s portfolio choices are closely monitored by both novice and seasoned investors alike. Presently, Kela manages a portfolio of 15 stocks valued at approximately Rs 2,883 crore, making him a key figure in the equity market landscape.

Kela’s Portfolio Insights: A Deep Dive

When a celebrated investor like Kela makes notable adjustments to his investments, it’s essential to analyze these changes closely. Could these stocks be on the verge of becoming the next big winners in the market? Let’s explore Kela’s recent interests in Prataap Snacks Ltd and Kopran Ltd, two companies that have piqued his interest.

Prataap Snacks Ltd: A Snack Industry Leader

Prataap Snacks Ltd is a major contender in India’s snack food industry, offering a wide range of products such as potato chips, extruded snacks, and traditional Indian namkeen under its popular brands, Yellow Diamond and Rich Feast. With a current market capitalization of Rs 2,778 crore, Prataap Snacks ranks as a leader in the Rings category and is among the top five in Western Savoury Snacks.

Recently, Kela acquired a 4.6% stake in Prataap Snacks, amassing 1.1 million shares valued at Rs 128 crore. This move raises questions about what Kela sees in the company’s future potential.

Sales Growth: From Rs 1,092 crore in FY19 to Rs 1,618 crore in FY24, Prataap has exhibited an impressive 8% compounded growth over five years.
EBITDA Performance: The company’s EBITDA grew from Rs 78 crore in FY19 to Rs 141 crore in FY24, reflecting a 13% compound annual growth rate.
Profit Trends: While profits increased from Rs 45 crore in FY19 to Rs 53 crore in FY24, Prataap Snacks reported a loss of Rs 23 crore for the first nine months of FY25.

The stock’s price has surged from about Rs 465 in April 2020 to Rs 1,164 by April 2025, marking a 150% increase. Despite this growth, the current price remains 20% below its peak of Rs 1,459.

Kopran Ltd: A Pharmaceutical Powerhouse

Founded in 1958, Kopran Ltd is a fully integrated pharmaceutical company producing high-quality formulations and active pharmaceutical ingredients (APIs). With a market cap of Rs 918 crore, Kopran is a significant player in the pharmaceutical sector.

Kela has steadily increased his stake in Kopran from 1.04% in March 2023 to 1.5% in March 2025, coinciding with an uptick in Foreign Institutional Investments (FIIs) from 0.86% to 1.12%. This increase comes amid a broader FII withdrawal from the market, making it noteworthy.

Sales Growth: Kopran’s sales rose from Rs 358 crore in FY19 to Rs 615 crore in FY24, achieving an 11% compound growth.
EBITDA Growth: The EBITDA jumped from Rs 46 crore in FY19 to Rs 74 crore in FY24, indicating a 10% growth.
Profitability: Over the same period, profits increased from Rs 24 crore to Rs 51 crore, showcasing a 16% compound growth.

Kopran’s stock price has seen a remarkable rise from Rs 28 in April 2020 to Rs 190 as of April 2025, reflecting a staggering 578% increase. However, it is still 49% below its all-time high of Rs 370.

Strategic Moves or Risky Bets?

Madhusudan Kela’s recent investments in Prataap Snacks and Kopran Ltd highlight his keen insight into the market. Both stocks are currently trading below their historical highs, which has sparked curiosity among investors. Kela’s proven track record suggests he may have identified significant growth opportunities that others might overlook.

Prataap Snacks is expanding its presence in the rapidly growing snack industry, especially in the namkeen segment.
Kopran is strategically positioning itself for growth in pharmaceuticals and diagnostics through a planned merger with Kopran Laboratories Ltd, which aims to leverage existing relationships to enhance market reach.

While both companies face challenges—such as Prataap’s recent financial losses and Kopran’s competitive landscape—Kela’s confidence in these stocks may indicate hidden value waiting to be realized. As these narratives unfold, investors are encouraged to keep a close watch on these dynamic players in the market.

For further insights into investment strategies and market trends, consider exploring additional resources and expert analyses.